| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.57e-06 | 5 | 166 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.31e-05 | 37 | 166 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.50e-05 | 38 | 166 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.52e-04 | 13 | 166 | 3 | GO:0008046 | |
| GeneOntologyBiologicalProcess | cell recognition | 5.35e-06 | 198 | 168 | 10 | GO:0008037 | |
| GeneOntologyBiologicalProcess | neuron recognition | 8.42e-06 | 59 | 168 | 6 | GO:0008038 | |
| GeneOntologyBiologicalProcess | synapse assembly | SLC25A46 GABRG3 CUX2 NRCAM NEGR1 LRFN5 ROBO1 CTNNB1 MDGA1 SDK1 EPHB1 | 4.66e-05 | 308 | 168 | 11 | GO:0007416 |
| GeneOntologyCellularComponent | manchette | 7.25e-05 | 28 | 169 | 4 | GO:0002177 | |
| Domain | FN3_dom | PAPPA2 FLNC MYOM1 NRCAM COL20A1 OBSCN NCAM1 RIMBP3 IGSF22 LRFN5 FNDC11 ROBO1 RIMBP3C RIMBP3B MDGA1 USH2A SDK1 HCFC1 EPHA1 EPHB1 | 1.38e-15 | 209 | 160 | 20 | IPR003961 |
| Domain | Ig-like_fold | PAPPA2 FLNC MYOM1 NRCAM TAPBPL COL20A1 OBSCN NCAM1 OPCML RIMBP3 IGSF22 HMCN2 CD19 NEGR1 SIGIRR NTM LRFN5 FNDC11 VCAN VSIG10L FCRLB ROBO1 LSAMP RIMBP3C BCAM RIMBP3B MDGA1 USH2A SDK1 HCFC1 EPHA1 EPHB1 | 7.30e-15 | 706 | 160 | 32 | IPR013783 |
| Domain | - | PAPPA2 FLNC MYOM1 NRCAM TAPBPL COL20A1 OBSCN NCAM1 OPCML RIMBP3 IGSF22 CD19 NEGR1 SIGIRR NTM LRFN5 FNDC11 VCAN VSIG10L FCRLB ROBO1 LSAMP RIMBP3C BCAM RIMBP3B MDGA1 USH2A SDK1 HCFC1 EPHA1 EPHB1 | 8.85e-15 | 663 | 160 | 31 | 2.60.40.10 |
| Domain | FN3 | MYOM1 NRCAM COL20A1 OBSCN NCAM1 RIMBP3 IGSF22 LRFN5 FNDC11 ROBO1 RIMBP3C RIMBP3B MDGA1 USH2A SDK1 HCFC1 EPHA1 EPHB1 | 1.05e-13 | 199 | 160 | 18 | PS50853 |
| Domain | FN3 | PAPPA2 FLNC MYOM1 NRCAM COL20A1 OBSCN NCAM1 IGSF22 ROBO1 RIMBP3C RIMBP3B MDGA1 USH2A SDK1 HCFC1 EPHA1 EPHB1 | 4.06e-13 | 185 | 160 | 17 | SM00060 |
| Domain | IGc2 | MYOM1 NRCAM OBSCN NCAM1 OPCML IGSF22 HMCN2 NEGR1 NTM LRFN5 VSIG10L ROBO1 LSAMP BCAM MDGA1 SDK1 | 1.93e-10 | 235 | 160 | 16 | SM00408 |
| Domain | Ig_sub2 | MYOM1 NRCAM OBSCN NCAM1 OPCML IGSF22 HMCN2 NEGR1 NTM LRFN5 VSIG10L ROBO1 LSAMP BCAM MDGA1 SDK1 | 1.93e-10 | 235 | 160 | 16 | IPR003598 |
| Domain | IG | MYOM1 NRCAM TAPBPL OBSCN NCAM1 OPCML IGSF22 HMCN2 CD19 NEGR1 NTM LRFN5 VCAN VSIG10L FCRLB ROBO1 LSAMP BCAM MDGA1 SDK1 | 5.83e-10 | 421 | 160 | 20 | SM00409 |
| Domain | Ig_sub | MYOM1 NRCAM TAPBPL OBSCN NCAM1 OPCML IGSF22 HMCN2 CD19 NEGR1 NTM LRFN5 VCAN VSIG10L FCRLB ROBO1 LSAMP BCAM MDGA1 SDK1 | 5.83e-10 | 421 | 160 | 20 | IPR003599 |
| Domain | Ig_I-set | MYOM1 NRCAM OBSCN NCAM1 OPCML IGSF22 HMCN2 NEGR1 NTM LRFN5 ROBO1 LSAMP MDGA1 SDK1 | 9.89e-10 | 190 | 160 | 14 | IPR013098 |
| Domain | I-set | MYOM1 NRCAM OBSCN NCAM1 OPCML IGSF22 HMCN2 NEGR1 NTM LRFN5 ROBO1 LSAMP MDGA1 SDK1 | 9.89e-10 | 190 | 160 | 14 | PF07679 |
| Domain | IG_LIKE | MYOM1 NRCAM TAPBPL OBSCN NCAM1 OPCML IGSF22 HMCN2 CD19 NEGR1 SIGIRR NTM LRFN5 VCAN VSIG10L FCRLB ROBO1 LSAMP BCAM MDGA1 SDK1 | 1.40e-09 | 491 | 160 | 21 | PS50835 |
| Domain | Ig-like_dom | MYOM1 NRCAM TAPBPL OBSCN NCAM1 OPCML IGSF22 HMCN2 CD19 NEGR1 SIGIRR NTM LRFN5 VCAN VSIG10L FCRLB ROBO1 LSAMP BCAM MDGA1 SDK1 | 2.15e-09 | 503 | 160 | 21 | IPR007110 |
| Domain | fn3 | MYOM1 NRCAM COL20A1 OBSCN NCAM1 IGSF22 ROBO1 USH2A SDK1 EPHA1 EPHB1 | 1.52e-07 | 162 | 160 | 11 | PF00041 |
| Domain | Quinoprotein_ADH-like_supfam | 3.29e-07 | 53 | 160 | 7 | IPR011047 | |
| Domain | ig | 3.89e-05 | 190 | 160 | 9 | PF00047 | |
| Domain | Immunoglobulin | 3.89e-05 | 190 | 160 | 9 | IPR013151 | |
| Domain | SAM_DOMAIN | 1.67e-04 | 95 | 160 | 6 | PS50105 | |
| Domain | SAM | 1.87e-04 | 97 | 160 | 6 | IPR001660 | |
| Domain | Myotubularin-like_Pase_dom | 2.10e-04 | 14 | 160 | 3 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 2.10e-04 | 14 | 160 | 3 | PS51339 | |
| Domain | Myotubularin_fam | 2.10e-04 | 14 | 160 | 3 | IPR030564 | |
| Domain | Myotub-related | 2.10e-04 | 14 | 160 | 3 | PF06602 | |
| Domain | SAM_1 | 2.92e-04 | 68 | 160 | 5 | PF00536 | |
| Domain | LamGL | 4.33e-04 | 4 | 160 | 2 | SM00560 | |
| Domain | LamG-like | 4.33e-04 | 4 | 160 | 2 | IPR006558 | |
| Domain | SAM/pointed | 5.14e-04 | 117 | 160 | 6 | IPR013761 | |
| Domain | Glyco_transf_64 | 7.17e-04 | 5 | 160 | 2 | PF09258 | |
| Domain | Exostosin | 7.17e-04 | 5 | 160 | 2 | PF03016 | |
| Domain | Exostosin | 7.17e-04 | 5 | 160 | 2 | IPR004263 | |
| Domain | EXT_C | 7.17e-04 | 5 | 160 | 2 | IPR015338 | |
| Domain | HECT | 1.55e-03 | 27 | 160 | 3 | PF00632 | |
| Domain | HECTc | 1.55e-03 | 27 | 160 | 3 | SM00119 | |
| Domain | HECT_dom | 1.55e-03 | 27 | 160 | 3 | IPR000569 | |
| Domain | HECT | 1.55e-03 | 27 | 160 | 3 | PS50237 | |
| Pubmed | MTMR12 NEDD4L NRCAM WDR7 KIAA0232 GON4L FAM91A1 NEDD4 CAMKK2 TENM4 MROH1 NEGR1 MICAL3 KIF17 DYNC1H1 VPS13B PDZD2 | 2.73e-11 | 407 | 173 | 17 | 12693553 | |
| Pubmed | Spatiotemporal expression of IgLON family members in the developing mouse nervous system. | 2.95e-09 | 5 | 173 | 4 | 34599206 | |
| Pubmed | 1.33e-07 | 162 | 173 | 9 | 25826454 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.83e-07 | 232 | 173 | 10 | 25515538 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.82e-07 | 4 | 173 | 3 | 19091768 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.20e-06 | 5 | 173 | 3 | 12629516 | |
| Pubmed | Molecular determinants of voltage-gated sodium channel regulation by the Nedd4/Nedd4-like proteins. | 1.20e-06 | 5 | 173 | 3 | 15548568 | |
| Pubmed | 1.20e-06 | 5 | 173 | 3 | 17289006 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.20e-06 | 5 | 173 | 3 | 17855024 | |
| Pubmed | 1.20e-06 | 5 | 173 | 3 | 36002265 | ||
| Pubmed | 1.34e-06 | 17 | 173 | 4 | 28292929 | ||
| Pubmed | 1.38e-06 | 214 | 173 | 9 | 22199357 | ||
| Pubmed | 1.71e-06 | 18 | 173 | 4 | 18664271 | ||
| Pubmed | 2.11e-06 | 42 | 173 | 5 | 15146195 | ||
| Pubmed | 2.39e-06 | 6 | 173 | 3 | 37156795 | ||
| Pubmed | 2.39e-06 | 6 | 173 | 3 | 11748237 | ||
| Pubmed | 2.39e-06 | 6 | 173 | 3 | 15252135 | ||
| Pubmed | EPRS1 FLNC NEDD4L NRCAM WDR7 NCAM1 IDH2 OPCML PHGDH FASN SF3B1 TENM4 STXBP1 NEGR1 NTM VCAN LSAMP MICAL3 USP54 CTNNB1 DYNC1H1 GOT1 | 2.80e-06 | 1431 | 173 | 22 | 37142655 | |
| Pubmed | Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. | 4.17e-06 | 7 | 173 | 3 | 23644597 | |
| Pubmed | 4.17e-06 | 7 | 173 | 3 | 11046148 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 6.52e-06 | 91 | 173 | 6 | 28558017 | |
| Pubmed | The Nedd4-like protein KIAA0439 is a potential regulator of the epithelial sodium channel. | 6.65e-06 | 8 | 173 | 3 | 11244092 | |
| Pubmed | Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. | 6.65e-06 | 8 | 173 | 3 | 17719543 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 8.12e-06 | 26 | 173 | 4 | 34848499 | |
| Pubmed | ADAMTS19 TICRR ZNF135 FAM234A PCNX3 OBSCN GON4L FAM91A1 ARFIP1 DALRD3 COL18A1 MROH1 VCAN NCAPD2 MICAL3 NUP188 USP54 EIF2AK3 EPHA1 | 1.11e-05 | 1215 | 173 | 19 | 15146197 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 FLNC ANKS6 MAN2B1 PCNX3 OBSCN EXTL3 TEP1 FASN MROH1 NCAPD2 MICAL3 NUP188 BCAM CABIN1 HCFC1 DYNC1H1 GAREM1 | 1.11e-05 | 1105 | 173 | 18 | 35748872 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | EPRS1 NEDD4L NRCAM DYNC2H1 EXT1 SF3B1 ROBO1 CTNNB1 SDK1 DYNC1H1 | 1.36e-05 | 358 | 173 | 10 | 32460013 |
| Pubmed | EPRS1 TMEM214 ARFIP1 JMJD1C PHGDH FASN CDK5RAP3 PPP2R5D NCAPD2 ROBO1 MICAL3 EIF2AK3 HCFC1 DYNC1H1 | 1.36e-05 | 708 | 173 | 14 | 39231216 | |
| Pubmed | 1.41e-05 | 10 | 173 | 3 | 25092867 | ||
| Pubmed | 1.46e-05 | 30 | 173 | 4 | 27568566 | ||
| Pubmed | Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. | 1.94e-05 | 11 | 173 | 3 | 20404343 | |
| Pubmed | 1.94e-05 | 11 | 173 | 3 | 22773947 | ||
| Pubmed | 1.94e-05 | 11 | 173 | 3 | 39349721 | ||
| Pubmed | 1.94e-05 | 11 | 173 | 3 | 34927784 | ||
| Pubmed | Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein. | 1.94e-05 | 11 | 173 | 3 | 25963657 | |
| Pubmed | Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects. | 2.46e-05 | 2 | 173 | 2 | 24616287 | |
| Pubmed | Promoter-Specific Expression and Genomic Structure of IgLON Family Genes in Mouse. | 2.46e-05 | 2 | 173 | 2 | 28210208 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 27151216 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 21331365 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 23099107 | ||
| Pubmed | Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization. | 2.46e-05 | 2 | 173 | 2 | 32188705 | |
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 2.46e-05 | 2 | 173 | 2 | 16440056 | |
| Pubmed | Physiological Functions of the Ubiquitin Ligases Nedd4-1 and Nedd4-2. | 2.46e-05 | 2 | 173 | 2 | 37962894 | |
| Pubmed | Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production. | 2.46e-05 | 2 | 173 | 2 | 25679868 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 20377530 | ||
| Pubmed | TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. | 2.46e-05 | 2 | 173 | 2 | 11070163 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 23262292 | ||
| Pubmed | Down-regulating destruction: phosphorylation regulates the E3 ubiquitin ligase Nedd4-2. | 2.46e-05 | 2 | 173 | 2 | 19602703 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 25502651 | ||
| Pubmed | CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling. | 2.46e-05 | 2 | 173 | 2 | 27793695 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 34229059 | ||
| Pubmed | Calcium/calmodulin kinase kinase beta has a male-specific role in memory formation. | 2.46e-05 | 2 | 173 | 2 | 17207577 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 32710982 | ||
| Pubmed | Redirection of B cell responsiveness by transforming growth factor beta receptor. | 2.46e-05 | 2 | 173 | 2 | 12773615 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 22334678 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 12819783 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18333845 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18081712 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 12654522 | ||
| Pubmed | A novel mouse Nedd4 protein suppresses the activity of the epithelial Na+ channel. | 2.46e-05 | 2 | 173 | 2 | 11149908 | |
| Pubmed | Dietary sodium modulates nephropathy in Nedd4-2-deficient mice. | 2.46e-05 | 2 | 173 | 2 | 31802037 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 34330894 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 17213473 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 18768830 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 9545347 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 29605488 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 7891157 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 38755664 | ||
| Pubmed | A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy. | 2.46e-05 | 2 | 173 | 2 | 29073160 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 11502596 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 23818870 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 17015468 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 15556626 | ||
| Pubmed | M-cadherin-inhibited phosphorylation of ß-catenin augments differentiation of mouse myoblasts. | 2.46e-05 | 2 | 173 | 2 | 23138569 | |
| Pubmed | Regulation of polyunsaturated fat induced postprandial hypercholesterolemia by a novel gene Phc-2. | 2.46e-05 | 2 | 173 | 2 | 8190122 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FLNC UTP14A ADAR JMJD1C RXRB TEX36 FASN SF3B1 NCAPD2 CTNNB1 CABIN1 L3MBTL3 EIF2AK3 HCFC1 DYNC1H1 | 2.75e-05 | 857 | 173 | 15 | 25609649 |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 2.89e-05 | 118 | 173 | 6 | 27377895 | |
| Pubmed | Multiple loci influencing hippocampal degeneration identified by genome scan. | 3.33e-05 | 13 | 173 | 3 | 22745009 | |
| Pubmed | 3.44e-05 | 37 | 173 | 4 | 32201365 | ||
| Pubmed | 3.72e-05 | 403 | 173 | 10 | 30562941 | ||
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 4.23e-05 | 14 | 173 | 3 | 17662146 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.59e-05 | 256 | 173 | 8 | 33397691 | |
| Pubmed | 5.27e-05 | 15 | 173 | 3 | 23236378 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 6.11e-05 | 344 | 173 | 9 | 30333137 | |
| Pubmed | Huntingtin interacting proteins are genetic modifiers of neurodegeneration. | 6.20e-05 | 197 | 173 | 7 | 17500595 | |
| Pubmed | 6.46e-05 | 16 | 173 | 3 | 21920314 | ||
| Pubmed | 6.53e-05 | 347 | 173 | 9 | 17114649 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 18498246 | ||
| Pubmed | Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway. | 7.36e-05 | 3 | 173 | 2 | 21852580 | |
| Pubmed | Tril dampens Nodal signaling through Pellino2- and Traf6-mediated activation of Nedd4l. | 7.36e-05 | 3 | 173 | 2 | 34475212 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 34054729 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 12628440 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 15289605 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 20730100 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 12183361 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 8666668 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 27592306 | ||
| Pubmed | The high-affinity choline transporter CHT1 is regulated by the ubiquitin ligase Nedd4-2. | 7.36e-05 | 3 | 173 | 2 | 22361880 | |
| Pubmed | Nedd4-2-mediated ubiquitination facilitates processing of surfactant protein-C. | 7.36e-05 | 3 | 173 | 2 | 19423771 | |
| Pubmed | Alternative splicing determines the domain structure of WWP1, a Nedd4 family protein. | 7.36e-05 | 3 | 173 | 2 | 11779188 | |
| Cytoband | 22q11.21 | 6.66e-05 | 111 | 173 | 5 | 22q11.21 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | MYOM1 NRCAM OBSCN NCAM1 OPCML IGSF22 HMCN2 NEGR1 NTM LRFN5 ROBO1 LSAMP MDGA1 SDK1 | 1.26e-12 | 161 | 112 | 14 | 593 |
| GeneFamily | Fibronectin type III domain containing | MYOM1 NRCAM COL20A1 OBSCN NCAM1 IGSF22 LRFN5 ROBO1 USH2A SDK1 EPHA1 EPHB1 | 3.14e-10 | 160 | 112 | 12 | 555 |
| GeneFamily | I-set domain containing|IgLON cell adhesion molecules | 6.94e-09 | 5 | 112 | 4 | 1052 | |
| GeneFamily | Immunoglobulin like domain containing | 3.18e-06 | 193 | 112 | 9 | 594 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 9.97e-05 | 15 | 112 | 3 | 903 | |
| GeneFamily | Exostosin glycosyltransferase family | 3.76e-04 | 5 | 112 | 2 | 431 | |
| GeneFamily | WD repeat domain containing | 1.23e-03 | 262 | 112 | 7 | 362 | |
| GeneFamily | Sterile alpha motif domain containing | 2.18e-03 | 88 | 112 | 4 | 760 | |
| GeneFamily | Dyneins, cytoplasmic | 2.84e-03 | 13 | 112 | 2 | 538 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.30e-03 | 14 | 112 | 2 | 1095 | |
| GeneFamily | StAR related lipid transfer domain containing | 3.79e-03 | 15 | 112 | 2 | 759 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.31e-03 | 57 | 112 | 3 | 1179 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-07 | 191 | 168 | 8 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-07 | 191 | 168 | 8 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.34e-07 | 193 | 168 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.24e-07 | 196 | 168 | 8 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.24e-07 | 196 | 168 | 8 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 8.56e-07 | 197 | 168 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 8.56e-07 | 197 | 168 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.40e-06 | 146 | 168 | 7 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.47e-06 | 159 | 168 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-06 | 179 | 168 | 7 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.03e-06 | 182 | 168 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.80e-06 | 70 | 168 | 5 | e1ac00f4a519b6ada89f591e549874bd3eed0ca1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.80e-06 | 70 | 168 | 5 | 27e12c0f43a996bcbed285c5ee668bef5a786d80 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.80e-06 | 70 | 168 | 5 | b6815131e87e81c10e65bc398a84dab5a74b32ac | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.20e-06 | 187 | 168 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.71e-06 | 189 | 168 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.98e-06 | 190 | 168 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.98e-06 | 190 | 168 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.26e-06 | 191 | 168 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.55e-06 | 192 | 168 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 9.14e-06 | 194 | 168 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.14e-06 | 194 | 168 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.78e-06 | 196 | 168 | 7 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.78e-06 | 196 | 168 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | myeloid-pro-pDC|World / Lineage and Cell class | 1.01e-05 | 197 | 168 | 7 | 8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 198 | 168 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 198 | 168 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 198 | 168 | 7 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 198 | 168 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 198 | 168 | 7 | 02d0d8a212e09c0962ab1dae6a885d26d357f66a | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 1.48e-05 | 139 | 168 | 6 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-05 | 148 | 168 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.27e-05 | 150 | 168 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 3.04e-05 | 158 | 168 | 6 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.63e-05 | 163 | 168 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 3.75e-05 | 164 | 168 | 6 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 166 | 168 | 6 | 67370c49d7aedcb4eca802095f06b30f6bbf8919 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 166 | 168 | 6 | 7f4e5976ede6478636aa567d6fc2b56ff7295fb8 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 168 | 168 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 170 | 168 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.89e-05 | 172 | 168 | 6 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 4.89e-05 | 172 | 168 | 6 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 5.22e-05 | 174 | 168 | 6 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.39e-05 | 175 | 168 | 6 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 5.39e-05 | 175 | 168 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 5.39e-05 | 175 | 168 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.39e-05 | 175 | 168 | 6 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 176 | 168 | 6 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-05 | 177 | 168 | 6 | 41cbb2c109eaa7be366fc0510cce64abc06837b4 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 5.92e-05 | 178 | 168 | 6 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.92e-05 | 178 | 168 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 181 | 168 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.49e-05 | 181 | 168 | 6 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 181 | 168 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.69e-05 | 182 | 168 | 6 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.69e-05 | 182 | 168 | 6 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 6.69e-05 | 182 | 168 | 6 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.69e-05 | 182 | 168 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 6.69e-05 | 182 | 168 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-05 | 183 | 168 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 184 | 168 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-05 | 185 | 168 | 6 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.33e-05 | 185 | 168 | 6 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-05 | 185 | 168 | 6 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-05 | 186 | 168 | 6 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.77e-05 | 187 | 168 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.77e-05 | 187 | 168 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 168 | 6 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.00e-05 | 188 | 168 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.24e-05 | 189 | 168 | 6 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.24e-05 | 189 | 168 | 6 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 8.24e-05 | 189 | 168 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.24e-05 | 189 | 168 | 6 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.24e-05 | 189 | 168 | 6 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-05 | 189 | 168 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 190 | 168 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.48e-05 | 190 | 168 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.48e-05 | 190 | 168 | 6 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.48e-05 | 190 | 168 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.48e-05 | 190 | 168 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 190 | 168 | 6 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 190 | 168 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.48e-05 | 190 | 168 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.73e-05 | 191 | 168 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 191 | 168 | 6 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.73e-05 | 191 | 168 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.99e-05 | 192 | 168 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.99e-05 | 192 | 168 | 6 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.99e-05 | 192 | 168 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| Disease | Liddle syndrome (implicated_via_orthology) | 6.23e-07 | 4 | 160 | 3 | DOID:0050477 (implicated_via_orthology) | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 1.78e-05 | 29 | 160 | 4 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 NRCAM DYNC2H1 OBSCN H6PD ADAR RXRB PHGDH NEDD4 FASN NLRP9 ROBO1 USP54 MMP3 CTNNB1 L3MBTL3 VPS13B | 7.90e-05 | 1074 | 160 | 17 | C0006142 |
| Disease | alcoholic liver disease | 8.58e-05 | 82 | 160 | 5 | EFO_0008573 | |
| Disease | left ventricular systolic function measurement | 9.55e-05 | 44 | 160 | 4 | EFO_0008206 | |
| Disease | Mammary Neoplasms | NRCAM DYNC2H1 H6PD ADAR RXRB PHGDH TGFBR2 FASN MMP3 CTNNB1 L3MBTL3 | 1.51e-04 | 527 | 160 | 11 | C1458155 |
| Disease | hereditary multiple exostoses (implicated_via_orthology) | 1.74e-04 | 4 | 160 | 2 | DOID:206 (implicated_via_orthology) | |
| Disease | Hepatitis | 2.23e-04 | 22 | 160 | 3 | HP_0012115 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.51e-04 | 103 | 160 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | Hypertrophic Cardiomyopathy | 2.63e-04 | 57 | 160 | 4 | C0007194 | |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 2.89e-04 | 5 | 160 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | triglycerides to total lipids in IDL percentage | 3.87e-04 | 63 | 160 | 4 | EFO_0022329 | |
| Disease | serum gamma-glutamyl transferase measurement | CUX2 NEDD4L PCNX3 GON4L ZC3H11B JMJD1C CAMKK2 TENM4 ROBO1 MICAL3 CABIN1 L3MBTL3 EPHA1 EPHB1 | 4.78e-04 | 914 | 160 | 14 | EFO_0004532 |
| Disease | body weight | PAPPA2 GABRG3 CUX2 NRCAM GON4L OPCML ACSL3 FASN LIPC NEGR1 LRFN5 CHRDL1 LSAMP L3MBTL3 EIF2AK3 PDZD2 EPHB1 | 5.16e-04 | 1261 | 160 | 17 | EFO_0004338 |
| Disease | triglycerides to total lipids in very small VLDL percentage | 5.47e-04 | 69 | 160 | 4 | EFO_0022341 | |
| Disease | Ovarian neoplasm | 6.03e-04 | 7 | 160 | 2 | cv:C0919267 | |
| Disease | centronuclear myopathy (implicated_via_orthology) | 6.03e-04 | 7 | 160 | 2 | DOID:14717 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 6.16e-04 | 525 | 160 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.16e-04 | 525 | 160 | 10 | C1257931 | |
| Disease | refractive error, age at onset, Myopia | 6.67e-04 | 193 | 160 | 6 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | mood instability measurement | 6.81e-04 | 128 | 160 | 5 | EFO_0008475 | |
| Disease | Breast Carcinoma | 7.43e-04 | 538 | 160 | 10 | C0678222 | |
| Disease | age at initiation of corrective lens use | 8.01e-04 | 8 | 160 | 2 | EFO_0021781 | |
| Disease | ovarian neoplasm | 8.38e-04 | 134 | 160 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 9.25e-04 | 137 | 160 | 5 | C1140680 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.03e-03 | 9 | 160 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | waist-hip ratio | PAPPA2 CUX2 DYNC2H1 WWP2 ARFGEF1 ZC3H11B NCAM1 H6PD JMJD1C OPCML COL18A1 CAMKK2 CDK5RAP3 UBE2G1 ROBO1 L3MBTL3 | 1.06e-03 | 1226 | 160 | 16 | EFO_0004343 |
| Disease | Schizophrenia | NCAM1 GRIK1 OPCML CAMKK2 TENM4 STXBP1 EML5 LSAMP MMP3 CTNNB1 C9orf72 MDGA1 KIF17 | 1.09e-03 | 883 | 160 | 13 | C0036341 |
| Disease | lung cancer (is_marker_for) | 1.24e-03 | 39 | 160 | 3 | DOID:1324 (is_marker_for) | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 1.28e-03 | 10 | 160 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | intermediate density lipoprotein measurement | 1.31e-03 | 87 | 160 | 4 | EFO_0008595 | |
| Disease | Alzheimer disease | 1.38e-03 | 485 | 160 | 9 | MONDO_0004975 | |
| Disease | cocaine use | 1.56e-03 | 11 | 160 | 2 | C3496069 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.56e-03 | 11 | 160 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | Situs Inversus | 1.56e-03 | 11 | 160 | 2 | C0037221 | |
| Disease | smoking status measurement | WWP2 NCAM1 GRIK1 ADAR OPCML TENM4 NEGR1 NTM LSAMP MDGA1 USH2A SDK1 BRWD1 WDR72 EPHB1 | 1.67e-03 | 1160 | 160 | 15 | EFO_0006527 |
| Disease | Neurodevelopmental Disorders | 1.67e-03 | 93 | 160 | 4 | C1535926 | |
| Disease | concentration of large LDL particles measurement | 1.76e-03 | 44 | 160 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 1.76e-03 | 44 | 160 | 3 | EFO_0022225 | |
| Disease | Gastric Adenocarcinoma | 1.88e-03 | 45 | 160 | 3 | C0278701 | |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 2.13e-03 | 47 | 160 | 3 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | matrix metalloproteinase measurement | 2.19e-03 | 13 | 160 | 2 | EFO_0004744 | |
| Disease | myopathy (implicated_via_orthology) | 2.26e-03 | 48 | 160 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Alzheimer disease, educational attainment | 2.35e-03 | 247 | 160 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | sodium measurement | 2.43e-03 | 103 | 160 | 4 | EFO_0009282 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.54e-03 | 50 | 160 | 3 | EFO_0022334 | |
| Disease | smoking behavior | 2.68e-03 | 341 | 160 | 7 | EFO_0004318 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.69e-03 | 51 | 160 | 3 | EFO_0022331 | |
| Disease | susceptibility to rubella infection measurement | 2.85e-03 | 52 | 160 | 3 | EFO_0008418 | |
| Disease | thrombosis (is_implicated_in) | 2.93e-03 | 15 | 160 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 3.00e-03 | 53 | 160 | 3 | EFO_0022340 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.00e-03 | 53 | 160 | 3 | C4707243 | |
| Disease | free cholesterol in small LDL measurement | 3.00e-03 | 53 | 160 | 3 | EFO_0022271 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 3.00e-03 | 53 | 160 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 3.00e-03 | 53 | 160 | 3 | EFO_0022258 | |
| Disease | Ciliopathies | 3.08e-03 | 110 | 160 | 4 | C4277690 | |
| Disease | Intellectual Disability | 3.15e-03 | 447 | 160 | 8 | C3714756 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 3.17e-03 | 54 | 160 | 3 | EFO_0022244 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | p-cresol sulfate measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0010998 | |
| Disease | Cannabis use | 3.34e-03 | 16 | 160 | 2 | EFO_0007585 | |
| Disease | response to acetylsalicylate | 3.34e-03 | 16 | 160 | 2 | GO_1903492 | |
| Disease | cathepsin L1 measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0010619 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 3.50e-03 | 114 | 160 | 4 | EFO_0004529, EFO_0004611 | |
| Disease | ovarian cancer (is_implicated_in) | 3.51e-03 | 56 | 160 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | hippocampal atrophy | 3.51e-03 | 56 | 160 | 3 | EFO_0005039 | |
| Disease | Abnormality of refraction | DOCK3 GABRG3 ZC3H11B GRIK1 NEDD4 BMP3 NTM LRFN5 ROBO1 CTNNB1 | 3.82e-03 | 673 | 160 | 10 | HP_0000539 |
| Disease | urate measurement, spine bone mineral density | 3.88e-03 | 58 | 160 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | cholesterol in IDL measurement | 3.88e-03 | 58 | 160 | 3 | EFO_0021899 | |
| Disease | aspartate aminotransferase measurement | MRC1 CUX2 NEDD4L OBSCN ERVK13-1 OPCML LIPC HMCN2 ROBO1 KIAA2012 L3MBTL3 GOT1 | 3.92e-03 | 904 | 160 | 12 | EFO_0004736 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.05e-03 | 276 | 160 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | triglycerides to total lipids in small LDL percentage | 4.07e-03 | 59 | 160 | 3 | EFO_0022337 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 4.07e-03 | 59 | 160 | 3 | EFO_0022289 | |
| Disease | sphingomyelin measurement | 4.20e-03 | 278 | 160 | 6 | EFO_0010118 | |
| Disease | blood nickel measurement | 4.20e-03 | 120 | 160 | 4 | EFO_0007583 | |
| Disease | matrix metalloproteinase 12 measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0010590 | |
| Disease | glucuronate measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0010486 | |
| Disease | Hemangiosarcoma | 4.22e-03 | 18 | 160 | 2 | C0018923 | |
| Disease | total lipids in IDL | 4.27e-03 | 60 | 160 | 3 | EFO_0022161 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.27e-03 | 60 | 160 | 3 | EFO_0022233 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.33e-03 | 121 | 160 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | free cholesterol in IDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022181 | |
| Disease | free cholesterol in VLDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022276 | |
| Disease | metabolic syndrome | 4.79e-03 | 200 | 160 | 5 | EFO_0000195 | |
| Disease | puberty onset measurement | 4.85e-03 | 125 | 160 | 4 | EFO_0005677 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 4.90e-03 | 63 | 160 | 3 | EFO_0022335 | |
| Disease | melanoma | 4.99e-03 | 126 | 160 | 4 | EFO_0000756 | |
| Disease | Colorectal Carcinoma | FLNC NRCAM OBSCN ARFGEF1 F5 TGFBR2 UGT3A2 CTNNB1 NODAL EPHA1 | 5.11e-03 | 702 | 160 | 10 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VHVSGPIFVLKWNPR | 366 | Q0P6H9 | |
| ILPGSPVKRTWHRHL | 1516 | Q68DN1 | |
| QELTPRWTPKAAHVL | 356 | Q9H0X4 | |
| WDLVVFGHERPSRKP | 311 | Q8WVB6 | |
| GKIPIRWTAPEAIAH | 786 | P21709 | |
| HSIKVPSESLWLPDI | 101 | Q05901 | |
| PTGTVPKWDSHIRAA | 266 | P12645 | |
| LTVKRTPHEAWRVPL | 26 | Q9NX77 | |
| SGPEHPELWRLTVAS | 221 | O42043 | |
| SGPEHPELWRLTVAS | 331 | Q9UKH3 | |
| HTIPLSVIPKTDWGV | 971 | P13611 | |
| WKPLIHSPSRTPVLV | 431 | Q9NZJ5 | |
| FKTTIPHALLTWRPN | 1531 | Q9Y6D6 | |
| LEVPHIQTRWKHPSV | 126 | P39086 | |
| HIKLKTPGVDAPSWL | 356 | P53367 | |
| VIVGLLKFWPKTHSP | 361 | Q14738 | |
| WTSPQVIKETHKPLG | 541 | P30038 | |
| WPHGITIVTPDRKFL | 321 | O75689 | |
| PLPVLEKWKNITGHT | 336 | Q4G176 | |
| LWHTVTLSSPLVGRP | 156 | Q8N531 | |
| SVSDLLSRPKPWHKL | 1081 | O14529 | |
| PGVLKTHRLPWSRDL | 236 | Q149M9 | |
| RHASPGVLVVSWLPV | 1096 | A6NNM3 | |
| RHASPGVLVVSWLPV | 1096 | A6NJZ7 | |
| WEKISAKGPTTAPLH | 866 | Q8TE59 | |
| EHSVLDLWRTKPPKG | 391 | Q4KMZ1 | |
| VGWCKEHRRTLITPP | 426 | Q96JM7 | |
| PAIHWISPEGKLISN | 316 | Q96NI6 | |
| HIPTWGFNSVRLPTK | 106 | Q8N8L6 | |
| QSEKVRLHWPTSLPS | 341 | Q9Y5P4 | |
| LVTGHPRPQVRWTKT | 61 | Q8NFP4 | |
| TSIILEWHPPRETGG | 336 | P54762 | |
| AHLTWEPPSVTSGKI | 1906 | P51610 | |
| THELTSRVTPIPGDW | 2281 | Q8WXI7 | |
| PSHWPLIKATVGLIR | 501 | P35222 | |
| ERIGWRALVHPKTHP | 196 | Q7RTP6 | |
| VEQWGTPEKLPRAHT | 1271 | P46934 | |
| LATGKPEPSISWRHI | 161 | Q7Z3B1 | |
| GRPEPTVTWRHISPK | 161 | Q9P121 | |
| LAEVHWDPVPLKSIR | 861 | Q92823 | |
| SPDPRKETWILHSQI | 41 | Q9Y216 | |
| LQRHSSKPVLPTSGW | 711 | Q9C0I1 | |
| KGVPIQTPREHSWIS | 91 | Q9XRX5 | |
| RGSPPIHVSWLKDGL | 3346 | Q8NDA2 | |
| EPAPKITWHRDGIVL | 3621 | Q8NDA2 | |
| TRIGVPDIKLHPWVT | 396 | Q8N5S9 | |
| LGLPSSKWVHPENAV | 876 | Q15652 | |
| HIGPAIPEVSSVWFK | 521 | Q658Y4 | |
| KLEPELHLISSFWPS | 321 | P08254 | |
| SRSQKVGVAWVEPHP | 116 | Q9GZN4 | |
| VSRSPKLEVWLSHEG | 1496 | Q9H6A9 | |
| WAVVPPSHTKGSLLQ | 946 | Q92628 | |
| DPPLSGTTHIWIRVT | 216 | Q9Y5G3 | |
| GWSPPRSRVSLHKED | 1576 | O15018 | |
| EIKVIPTPSADHWAL | 326 | P35913 | |
| GKDVLRHPTWPQKSV | 1676 | P39060 | |
| LWLEEGKPSHQPLTR | 456 | Q9H706 | |
| VPTKPIKHTIIISWG | 731 | Q14315 | |
| NLSPVGRVTPKEWKH | 66 | Q8TF08 | |
| STPVWRPPLKHASLE | 456 | Q0VF49 | |
| IIPWSTGPRHSGLVL | 436 | P11150 | |
| SGIPNLGVWPKRIHT | 21 | P0C7V9 | |
| VGVLIKPSWVLAPAH | 41 | A4D1T9 | |
| HLGEPPWVATIKLSG | 621 | Q86UU5 | |
| RSWKDSSLPPHILEV | 391 | Q9BUQ8 | |
| IEHLSPWIKSPRGHE | 921 | Q8NDA8 | |
| SVKVEGRPVPTVHWL | 5391 | Q5VST9 | |
| HPLRWLVRTKPTKSS | 5636 | Q5VST9 | |
| GRPEPTVTWRHLSVK | 161 | Q14982 | |
| QLIVNPRGWKPSVTH | 136 | Q99463 | |
| TNKSLTIHWLPPISG | 856 | Q9BXP8 | |
| PKDTFRLWLTAEVHP | 3801 | Q8NCM8 | |
| DSGKLAAPWHIPTIA | 991 | Q711Q0 | |
| PHISWKRESGIPIKE | 96 | Q8N9C0 | |
| TWIESISELHRSKPP | 181 | Q9NQC8 | |
| VPGWTKPITIGRHAH | 161 | P48735 | |
| EAKEPHVSSVLPWII | 836 | Q9Y6J0 | |
| HSNSPRWGEIIKLPI | 481 | Q8IZD9 | |
| QGTTPPIWHLTDKKR | 346 | P55265 | |
| KHRWPATAVPVVVIE | 526 | Q16394 | |
| ILSGNTAHWSTKPPI | 1046 | P17927 | |
| VVSPWTIPSEIHKIL | 3116 | Q9H799 | |
| PPQVEVHVWTIRKGI | 371 | Q9BU40 | |
| KTTSLLHPDSSRWIP | 351 | Q99928 | |
| SGPEHPELWRLTVAS | 221 | P61566 | |
| SGPEHPELWRLTVAS | 221 | P61567 | |
| SVSRGPLSWTHVHPK | 206 | P15391 | |
| SLQVSWTPPLGRVLH | 756 | Q9P218 | |
| SRSHSLLPPWVDLKE | 101 | Q6ZV77 | |
| LPRGRIPTSWVHEET | 411 | Q8NHY3 | |
| WRDSLTLHTKPEPLE | 296 | Q9BVV2 | |
| SHITRKPPIKVTSRW | 841 | O43909 | |
| WRTGTEPSVVERPHL | 241 | Q96JB5 | |
| PTFGPDSVEHWIKRV | 31 | Q8NCU4 | |
| KVWPHLALRVPAFET | 386 | Q96CU9 | |
| HVSGKPDTQERWLPS | 2066 | Q3T8J9 | |
| RLEALKTPGTWNHIT | 341 | P17174 | |
| HSKVRQPWSIPVLPD | 436 | Q68DC2 | |
| FHPPVWITDTTLRKS | 941 | Q9NSI6 | |
| WVKLGSLKPHLFPVT | 166 | Q9UPI3 | |
| SGPEHPELWRLTVAS | 331 | P61565 | |
| VVKFPTKAHTTPWGL | 311 | P07359 | |
| PVSRWAQIHLVKTPL | 671 | O00754 | |
| VVPEIKLHPWVTRHG | 436 | Q96RR4 | |
| SHVRDLPPVSGSIIW | 636 | Q14204 | |
| PGGPVWIKETRTRHL | 21 | Q5D0E6 | |
| PSIHIWDTETIKPLS | 751 | Q05BV3 | |
| AAEPVTFHVPWKRLL | 6 | Q8IXQ3 | |
| SLHPPWTTIFKGERV | 26 | Q6BAA4 | |
| VGKNTHPSLWPDIIS | 496 | Q6SJ93 | |
| GTPLISPLIKWDHSL | 826 | P49327 | |
| TLVSRVGHEPKKWPI | 756 | O95479 | |
| LLPIISWPHTTKVQG | 166 | Q6ICI0 | |
| VHGLPTPALRWTKDS | 386 | P50895 | |
| PQVTWFREGHKIIPS | 221 | Q7Z5N4 | |
| AWVIPPISVSENHKR | 46 | P55291 | |
| HWDKILGTLRTASVP | 256 | O95992 | |
| LTPAQALRHPWISKS | 511 | O43781 | |
| LPVLLPRHFKWIIGS | 221 | Q8NG08 | |
| PITKISHIPPSRWAL | 296 | Q92613 | |
| ILGPRVRHIWAPKTE | 36 | Q96LT7 | |
| GFWKIPHPVITKTSL | 891 | Q9P2E2 | |
| TPVTFTKWLRGEPSH | 441 | P22897 | |
| KGINSTTIHLRWFPP | 1476 | O75445 | |
| PHPSRDFVVLRTWKT | 1006 | Q9Y3M8 | |
| KVTWLAETTHALPIP | 606 | P07814 | |
| TPRVTKNEALWHPTL | 161 | Q9BX59 | |
| TLGHPVLRKSWSRPV | 316 | Q9NP31 | |
| GPEGKWIISSLTPKH | 301 | P12259 | |
| PVITWRHLTPTGREF | 161 | Q13449 | |
| TRPLSKWLKHPGALE | 156 | Q96S42 | |
| LWPGKVKVSVSLVHP | 176 | Q969Y0 | |
| RHASPGVLVVSWLPV | 1096 | Q9UFD9 | |
| PGIFTDISKVLPWIH | 281 | Q7RTZ1 | |
| HLVTLLLWRPGSVTP | 281 | Q6IA17 | |
| PLHIVLWTRIASTIP | 11 | P37173 | |
| LWTRIASTIPPHVQK | 16 | P37173 | |
| PIWIIIAAKHPATRT | 361 | Q96JW4 | |
| PATRTVLHSGWEPVI | 371 | Q96JW4 | |
| GKWEVLIGSTHILTP | 561 | P61764 | |
| VEWAKRIPHFSSLPL | 351 | P28702 | |
| IDSIEHIPPARWKLT | 371 | P55201 | |
| LRHIITVDGKPPTWS | 231 | O95573 | |
| ETVTKGFVHPDPLWI | 851 | Q15021 | |
| EEKIPHLTISHGPWI | 966 | Q7RTR0 | |
| VVSSLPPTIIWKHKG | 141 | P13591 | |
| PQWTVPLGDSRSHIK | 441 | A0A0J9YY54 | |
| HNTKTTTWERPLPPG | 321 | O00308 | |
| RSGIKLSSEPHLSPW | 261 | Q7Z2Z1 | |
| TFRLLVSVGHWLPKP | 46 | P52742 | |
| VSVGHWLPKPNVISL | 51 | P52742 | |
| LTPWLEFSKSGTHLP | 86 | O14609 | |
| LHGVLSVWRTLPKGT | 1431 | Q99973 | |
| LCWDVRTPKTPVLIH | 2086 | Q99973 | |
| PVLSWIHPENKTVIV | 226 | Q13496 | |
| SEFTPLPREVLHKWS | 181 | Q96AG3 | |
| KISPEKLVEWTSPGH | 261 | Q9UIV8 | |
| HTPSLRWDETPGRAK | 226 | O75533 | |
| TLPLWGSHLLTVVRP | 546 | Q6NUQ4 | |
| SGRITLWHIPDVPVS | 346 | Q3MJ13 | |
| IQPGSTVHVLRKSWP | 81 | Q96S82 | |
| PAKVWTDLRHTGFLP | 626 | Q5SRE5 | |
| TQLSTHEAPGRWKPV | 61 | D3DTV9 | |
| TVLSPEHPVRLWGRS | 121 | Q6N022 | |
| PAIAPIEHVLSGWKA | 166 | Q9BVJ6 | |
| SPVPTILWRKDGVLV | 481 | Q9Y6N7 | |
| LVSSHVTWGPTRKEP | 191 | Q86VD9 | |
| PVLTAVPGITWHLTK | 596 | A0A1B0GTU1 | |
| VPGITWHLTKQLPTK | 601 | A0A1B0GTU1 | |
| LTPWLEFSKSGTHLP | 86 | A2RUG3 | |
| HRGLWTLPSGKSVPV | 131 | Q13470 | |
| RIHVPWTKLGSEPVV | 66 | Q7Z7G8 | |
| LVALPGHIPWRKSRS | 411 | Q9UDV6 | |
| LTSAFSPHTKPWIGL | 321 | O43175 | |
| HSVTPVEISWPLDLK | 831 | Q86VR7 | |
| SHPLSPTQRLVGWID | 446 | Q3SY77 | |
| KPEERWLPIHTVETI | 106 | P62253 | |
| LVLPIVLWGRKAPTH | 6 | Q9Y4E6 | |
| IHALWTDFPPSKISR | 441 | Q05996 | |
| RWFPHIGLTQKTPES | 16 | Q5VZQ5 | |
| VIRLWHPNISTKPVG | 346 | B1ANS9 | |
| AKRSAGLVPSWRHIP | 691 | Q70EL1 | |
| APEFIIKPRSHTVWE | 276 | P52179 | |
| VHTTPGLPSGWEERK | 381 | Q96PU5 | |
| TIEQWGSPEKLPRAH | 926 | Q96PU5 |